Home > PS Ratio > NATCO PHARMA

NATCO PHARMA
PS (Price/Sales) Ratio

The Current P/S Ratio of NATCO PHARMA is 4.45.

Share Price ₹951.5Mar 28,2024
Market Cap ₹17,041.4 Cr
Sales-TTM₹3,828.4 CrTTM-Consolidated Results
Price/Sales4.45xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results
NATCO PHARMA is part of below Screeners ↓
Top Undervalued Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of NATCO PHARMA

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of NATCO PHARMA is calculated as :

Current Market Cap [ ₹17,041.4 Cr] as on Mar 28,2024

(/) Sales [ ₹3,828.4 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 4.45x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for NATCO PHARMA , the investors are currently willing to pay '4.45 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of NATCO PHARMA !

The chart below summarizes the trend in P/S Ratio of NATCO PHARMA over the last five years.

Historical PS (Price/Sales) ratio chart of NATCO PHARMA


PS Ratio Performance Analysis for NATCO PHARMA

- NATCO PHARMA 's latest p/e ratio is 4.45x.

- NATCO PHARMA 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 5.61x.

- NATCO PHARMA 's operated at median p/e ratio of 4.98x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, NATCO PHARMA 's p/e ratio peaked in Mar2021 at 7.34x.

- NATCO PHARMA 's p/e ratio hit its five-year low in Mar2023 of 3.8x.


How does NATCO PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
NATCO PHARMA 3,828.44.4517,041.4
SUN PHARMACEUTICAL INDUSTRIES LTD47,444.68.20388,812.0
CIPLA LTD25,350.24.76120,673.0
DR REDDYS LABORATORIES LTD27,212.53.77102,679.0
ZYDUS LIFESCIENCES LTD19,024.25.32101,152.0
DIVIS LABORATORIES LTD7,492.812.1891,234.9
MANKIND PHARMA LTD9,946.39.2592,029.2
TORRENT PHARMACEUTICALS LTD10,474.08.4188,034.7
LUPIN LTD19,480.13.7873,722.0
AUROBINDO PHARMA LTD27,894.72.2963,835.1
ABBOTT INDIA LTD5,753.49.9557,258.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs NATCO PHARMA 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.29x
Max industry PS 12.18x
Median industry PS 5.32x
Average industry PS 6.58x



You may also like the below Video Courses